LIST OF MEDICINES TO BE PROCURED

TABLET AUGMENTIN 625 DUO,TABLET ALLEGRA 120,TABLET PREGABA M 75,TABLET ALPRAX ZERO POINT TWENTY FIV

Goods
Qty:7,915

Tender Timeline

Tender Issue
May 29, 2025 at 1:45 PM

Tender Title: LIST OF MEDICINES TO BE PROCURED

Reference Number: 1aa5a5b42

Issuing Authority: Central Armed Police Forces, Ministry of Home Affairs

The tender aims to procure a comprehensive list of medicines and medical supplies essential for the operations of the Central Armed Police Forces. This procurement is crucial for ensuring the health and readiness of personnel engaged in various duties across the country.

Scope of Work and Objectives

The primary objective of this tender is to purchase specified pharmaceuticals, including tablets, capsules, syrups, injections, and topical ointments. The tender covers a total quantity of 7915 units of various medicines, among which are:

  • Tablet Augmentin 625 Duo
  • Tablet Allegra 120
  • Tablet Pregaba M 75
  • Tablet Alprox Zero Point Twenty Five MG
  • And other essential medicines.

The selected vendor will be responsible for delivering these medicines in accordance with the technical requirements and within the stipulated timeline to designated locations as determined by the Central Armed Police Forces.

Eligibility Criteria

To qualify for participation in this tender, bidders must meet the following requirements:

  • Must be a registered pharmaceutical entity with valid licenses pertinent to the sale and distribution of the listed medicines.
  • Compliance with all regulatory standards and guidelines as mandated by health authorities.
  • Proven track record in managing similar scale procurements.

Technical Requirements

Participants should demonstrate adherence to quality standards for pharmaceutical products as mandated by applicable health and safety regulations. The products must meet the specifications outlined in the tender documentation, ensuring both efficacy and safety.

Financial Requirements

Bidders need to submit a financial proposal that reflects competitive pricing while adhering to the budget constraints set forth by the Central Armed Police Forces. An Earnest Money Deposit (EMD) may be required, details of which will be elaborated in the tender documentation.

Document Submission Details

All bids must be submitted through the designated online portal. Each submission should include:

  • Cover letter
  • Detailed technical and financial quotes
  • Compliance documents
  • Certification from authorities regarding pharmaceutical standards.

Special Provisions

This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and startups. These entities may benefit from support schemes, including technical assistance and facilitations aimed at enhancing their capabilities.

Evaluation Process

The evaluation of bids will be conducted based on:

  • Compliance with technical specifications
  • Cost-effectiveness of proposals
  • Past performance in similar procurements.
    The selection criteria will prioritize the responsiveness and reliability of the offerings.

Delivery Locations

The medicines will need to be delivered to various locations predetermined by the Central Armed Police Forces, ensuring that all logistical considerations are taken into account.

Contact Information

For further inquiries, bidders are encouraged to reach out through the official communication channels provided in the tender documentation. Timely clarification is essential to ensure that all participants have a complete understanding of the expectations.

Summary

This tender offers a valuable opportunity for pharmaceutical suppliers to engage in a significant procurement process with the Central Armed Police Forces. Participation not only contributes to national safety but also enhances the suppliers' visibility and potential for sustained business growth in the sector.

Tender BOQ Items

24 Items
1.

TABLET AUGMENTIN 625 DUO

GSK

Qty:1000
Unit:nos
15
2.

TABLET ALLEGRA 120

SANOFI

Qty:500
Unit:nos
15
3.

TABLET PREGABA M 75

TORRENT

Qty:400
Unit:nos
15
4.

TABLET ALPRAX ZERO POINT TWENTY FIVE MG

TORRENT

Qty:50
Unit:nos
15
5.

TABLET BIFILAC

TABLETS INDIA

Qty:100
Unit:nos
15
6.

TABLET COMBIFLAM

SANOFI

Qty:2000
Unit:nos
15
7.

TABLET FLAGYL 400

ABBOTT

Qty:450
Unit:nos
15
8.

TABLET FOLVITE 5

PFIZER

Qty:600
Unit:nos
15
9.

TABLET TELMA 40

GLENMARK

Qty:1500
Unit:nos
15
10.

CAPSULE PANTOCID DSR

SUN PHARMA

Qty:1050
Unit:nos
15
11.

INHALER ASTHALIN 100 mcg

CIPLA

Qty:5
Unit:nos
15
12.

SYRUP OSTOCALCIUM 200 ML

GSK

Qty:20
Unit:bott
15
13.

SYRUP AZITHRAL 200 MG

ALEMBIC

Qty:30
Unit:bott
15
14.

SYRUP CLAVAM BID 30 ML

ALKEM

Qty:30
Unit:bott
15
15.

SYRUP MEFTAGESIC DS 60 ML

BLUE CROSS

Qty:30
Unit:bott
15
16.

INJ DERIPHYLLINE 2 ML

ZYDUS CADILA

Qty:10
Unit:amp
15
17.

INJ HYDROCORT 100

ABBOTT

Qty:10
Unit:vial
15
18.

INJ BUSCOGEST 2 ML

ZYDUS CADILA

Qty:10
Unit:amp
15
19.

INJ ACILOC 2 ML

CADILA

Qty:10
Unit:amp
15
20.

INJ VOVERAN AQUA 1 ML

DR REDDY S

Qty:20
Unit:amp
15
21.

OINT BURN HEAL 15 GM

CIPLA

Qty:20
Unit:tube
15
22.

JALONET PARAFFIN GUAZE DRESSING 10 CM X 10 CM

SMITH & NEPHEW

Qty:10
Unit:pkt
15
23.

STERILISED GUAZE SWAB 7 POINT 5 CM X 7 POINT 5 CM

ANY BRAND

Qty:50
Unit:nos
15
24.

HYDROGEN PEROXIDE 100 ML

ANY BRAND

Qty:10
Unit:bott
15

General Information

Item Category
TABLET AUGMENTIN 625 DUO , TABLET ALLEGRA 120 , TABLET PREGABA M 75 , TABLET ALPRAX ZERO POINT TWENTY FIVE MG , TABLET BIFILAC , TABLET COMBIFLAM , TABLET FLAGYL 400 , TABLET FOLVITE 5 , TABLET TELMA 40 , CAPSULE PANTOCID DSR , INHALER ASTHALIN 100 mcg , SYRUP OSTOCALCIUM 200 ML , SYRUP AZITHRAL 200 MG , SYRUP CLAVAM BID 30 ML , SYRUP MEFTAGESIC DS 60 ML , INJ DERIPHYLLINE 2 ML , INJ HYDROCORT 100 , INJ BUSCOGEST 2 ML , INJ ACILOC 2 ML , INJ VOVERAN AQUA 1 ML , OINT BURN HEAL 15 GM , JALONET PARAFFIN GUAZE DRESSING 10 CM X 10 CM , STERILISED GUAZE SWAB 7 POINT 5 CM X 7 POINT 5 CM , HYDROGEN PEROXIDE 100 ML

Financial Information

OEM Average Turnover
₹3.00 Lakh (s)
Minimum Turnover
₹3.00 Lakh (s)
Bid Offer Validity
90 (Days)
Past Performance
20 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Total value wise evaluation
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7903138.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • OEM Annual Turnover *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Frequently Asked Questions

The eligibility requirements include being a registered pharmaceutical entity capable of supplying the specified medicines. Bidders must hold valid licenses and certifications relevant to pharmaceuticals, ensuring compliance with national health regulations. Additionally, participants must demonstrate experience in similar procurements to strengthen their bid. A documented track record of successful delivery and adherence to quality standards will be advantageous during the evaluation process.

For participation in the tender, bidders must submit key certificates that include:

  • Valid drug license for distribution of pharmaceuticals.
  • Certificates affirming compliance with relevant quality control standards, such as ISO or equivalent.
  • Any additional industry-specific certifications aimed at ensuring the quality and safety of the products supplied. These documents validate the company’s capability and reliability in handling the specified medicines.

The submission methods for this tender primarily involve utilizing the designated online portal. Bidders must upload the required documents, including technical and financial proposals in prescribed formats. It is crucial to ensure all files are compiled clearly and accurately to facilitate smooth processing during the evaluation phase.

The payment terms for this tender will be specified in the tender documents, typically outlining conditions such as milestone payments based on delivery schedules or post-delivery payment provisions. It may also include prompts for invoice submission and potential performance guarantees required from the bidders to secure timely payments.

Yes, this tender actively encourages participation from Micro, Small, and Medium Enterprises (MSEs). Benefits include special provisions designed to facilitate their participation by lowering entry barriers and providing support mechanisms. MSEs can leverage these advantages to increase their competitive edge, complying with the ‘Make in India’ initiative by promoting local sourcing and production.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders